Biomay has more than two decades of expertise in the expression, purification and characterization of recombinant allergens. Biomay offers these allergens off-the-shelf at two quality levels: research-grade and GMP-grade for the production of therapies
Further information about Biomay is available online at: http://www.biomay.com
ABOUT CMC BIOLOGICS
CMC Biologics is a leading player, in offering integrated services for development and production of biopharmaceutical products. The Company specializes in process development and large-scale manufacturing of pharmaceutical proteins, in compliance with the most stringent cGMP standards, for use in preclinical studies, clinical trials and large-scale commercialization. CMC Biologics offers a broad range of services, including the development of cell lines, development processes, formulations and analytical tests. CMC Biologics has manufacturing sites in Copenhagen, Denmark and Washington, USA.
Further information about CMC Biologics is available online at: http://www.cmcbio.com
Stallergenes is a European biopharmaceutical company dedicated to immunotherapy treatments for the prevention and treatment of allergy-related respiratory diseases, such as allergic rhinoconjunctivitis, rhinitis and asthma. A pioneer and leader in sublingual immunotherapy treatments, Stallergenes devotes 21% of its turnover, in gross terms, to Research and Development and is actively involved in the development of a new therapeutic class: sublingual immunotherapy tablets.
In 2008, Stallergenes had a turnover of 171 million euros and more than
500,000 patients were treated with Stallergenes immunothe
Copyright©2009 PR Newswire.
All rights reserved